Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)

Clinical trial NCT03180684 · COMPLETED

Trial details

NCT number: NCT03180684
Sponsor: Inovio Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)Vulvar Dysplasia Vulvar Intraepithelial Neoplasia (VIN)VIN2 VIN3 Pre-cancerous Lesions of the Vulva Human Papillomavirus (HPV)

Start date: 2017-08-31
Primary completion: 2020-07-23
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.